CRISPR Therapeutics vs ONWARD Medical
CRISPR Therapeutics vs ONWARD Medical, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CRISPR Therapeutics is on 64/100 and ONWARD Medical on 50/100.
Where each one leads
CRISPR Therapeutics
- our overall score: 64/100 against 50/100
- domain rating: 67/100 against 3/100
- funding raised: $547M against $171M
ONWARD Medical
- agent readiness: 50/100 against 44/100
At a glance
| Measure | CRISPR Therapeutics | ONWARD Medical |
|---|---|---|
| What it is | Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology. | NeuroTech company developing therapies to restore movement and independence for people with spinal cord injuries. |
| Category | Biotechnology, Gene Editing, Therapeutics, Pharmaceuticals | Biotechnology, Medical Devices, Neurotechnology, Healthcare |
| Sells toBusiness model | B2B | B2B2C |
| Offering | Platform | Hardware |
| Founded | 2013 | 2015 |
| Headquarters | Zug, Switzerland | Eindhoven, Netherlands |
| Status | Active | Active |
Size, funding and growth
| Measure | CRISPR Therapeutics | ONWARD Medical |
|---|---|---|
| Total funding | $547M | $171M |
| Latest round | Series B | Private Placement |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CRISPR Therapeutics | ONWARD Medical |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 64/100 | 50/100 |
| Traction | 40/100 | 40/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 13/100 | 15/100 |
| Quality | 88/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (44/100) | D (50/100) |
| Domain ratingLink authority, 0-100 | 67/100 | 3/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CRISPR Therapeutics | ONWARD Medical |
|---|---|---|
| Hosting | Self Managed | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4 | Not detected |
CRISPR Therapeutics vs ONWARD Medical: common questions
Which is better, CRISPR Therapeutics or ONWARD Medical?
On our 0-100 score CRISPR Therapeutics rates higher (64/100 against 50/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do CRISPR Therapeutics and ONWARD Medical compare on the numbers?
CRISPR Therapeutics leads on our overall score (64/100 against 50/100), domain rating (67/100 against 3/100), funding raised ($547M against $171M). ONWARD Medical leads on agent readiness (50/100 against 44/100).
Read the full CRISPR Therapeutics review and pricing or the ONWARD Medical review and pricing. You can also browse other CRISPR Therapeutics alternatives we track.